The present disclosure provides modified nucleosides, nucleotides, and nucleic acids, and methods of using them.
本公开提供了修改的核苷酸,核苷酸和核酸,以及使用它们的方法。
TERMINALLY MODIFIED RNA
申请人:Chakraborty Tirtha
公开号:US20140147454A1
公开(公告)日:2014-05-29
The invention relates to compositions and methods for the manufacture and optimization of modified mRNA molecules via optimization of their terminal architecture.
ALTERNATIVE NUCLEIC ACID MOLECULES AND USES THEREOF
申请人:Moderna Therapeutics, Inc.
公开号:US20170136131A1
公开(公告)日:2017-05-18
The present disclosure provides alternative nucleosides, nucleotides, and nucleic acids, and methods of using them.
ALTERNATIVE NUCLEIC ACID MOLECULES CONTAINING REDUCED URACIL CONTENT AND USES THEREOF
申请人:ModernaTX, Inc.
公开号:US20180009866A1
公开(公告)日:2018-01-11
The present disclosure provides alternative nucleosides, nucleotides, and nucleic acids, and methods of using them. In some aspects, the disclosure provides mRNA wherein the uracil content has been modified and which may be particularly effective for use in therapeutic compositions, because they may benefit from both high expression levels and limited induction of the innate immune response. In some aspects, the disclosure provides methods for the production of pharmaceutical compositions including mRNA without reverse phase chromatography.